These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1903020)

  • 1. Tamoxifen and partial oestrogen agonism in postmenopausal women.
    Miodrag A; Ekelund P; Burton R; Castleden CM
    Age Ageing; 1991 Jan; 20(1):52-4. PubMed ID: 1903020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
    Englund DE; Johansson ED
    Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
    Wilking N; Carlström K; Sköldefors H; Theve NO; Wallgren A
    Acta Chir Scand; 1982; 148(4):345-9. PubMed ID: 6215811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
    Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
    Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
    Ellmén J; Hakulinen P; Partanen A; Hayes DF
    Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients.
    Geisler J; Ekse D; Hösch S; Lønning PE
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):193-5. PubMed ID: 7495698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
    Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer.
    Geisler J; Haarstad H; Gundersen S; Raabe N; Kvinnsland S; Lønning PE
    J Endocrinol; 1995 Aug; 146(2):359-63. PubMed ID: 7561649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.
    Bellet M; Gray KP; Francis PA; Láng I; Ciruelos E; Lluch A; Climent MA; Catalán G; Avella A; Bohn U; González-Martin A; Ferrer R; Catalán R; Azaro A; Rajasekaran A; Morales J; Vázquez J; Fleming GF; Price KN; Regan MM
    J Clin Oncol; 2016 May; 34(14):1584-93. PubMed ID: 26729437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women.
    Englund DE; Victor A; Johansson ED
    Maturitas; 1981 Aug; 3(2):125-33. PubMed ID: 6793811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen production and metabolism in peri-menopausal women.
    Reed MJ; Beranek PA; James VH
    Maturitas; 1986 Mar; 8(1):29-34. PubMed ID: 3084922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
    Isaacs AJ; Havard CW
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
    Keller PJ; Riedmann R; Fischer M; Gerber C
    Maturitas; 1981 Mar; 3(1):47-53. PubMed ID: 6789033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum estrogen levels in women during tamoxifen therapy.
    Lum SS; Woltering EA; Fletcher WS; Pommier RF
    Am J Surg; 1997 May; 173(5):399-402. PubMed ID: 9168075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between the karyopyknotic index and plasma oestrogen concentrations after the menopause.
    Morse AR; Hutton JD; Jacobs HS; Murray MA; James VH
    Br J Obstet Gynaecol; 1979 Dec; 86(12):981-3. PubMed ID: 526457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
    Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
    Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.